Rhus tox and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported only by a few people who take Rhus Tox.

The phase IV clinical study analyzes which people take Rhus tox and have Bleeding disorders. It is created by eHealthMe based on reports of 22 people who have side effects while taking Rhus tox from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 18, 2023

22 people reported to have side effects when taking Rhus tox.
Among them, 4 people (18.18%) have Bleeding disorders.

What is Rhus tox?

Rhus tox has active ingredients of poison ivy. eHealthMe is studying from 27 Rhus tox users for its effectiveness, alternative drugs and more.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 2,169 drugs and 1,570 conditions by eHealthMe.

Number of Rhus tox and Bleeding disorders reports submitted per year:

Could Rhus tox cause Bleeding disorders?

* Approximation only. Some reports may have incomplete information.

Do you take Rhus tox and have Bleeding disorders?

Check whether Bleeding disorders is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Bleeding disorders and when was it recovered:

Bleeding disorders in Rhus tox

Expand to all the drugs that have ingredients of poison ivy:

Bleeding disorders and drugs with ingredients of poison ivy

Alternative drugs to, pros and cons of Rhus tox:

Rhus tox (27 reports)

Bleeding disorders treatments and more:

Bleeding disorders (22,302 reports)

COVID vaccines that are related to Bleeding disorders:

Common drugs associated with Bleeding disorders:

All the drugs that are associated with Bleeding disorders:

Bleeding disorders (2,169 drugs)

Common conditions associated with Bleeding disorders:

Atrial fibrillation/flutter: 2,456 reports
Stroke: 855 reports
High blood pressure: 805 reports
Pain: 616 reports

All the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,570 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on poison ivy (the active ingredients of Rhus tox) and Rhus tox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.